KRT17 and renal carcinoma: Our descriptive analysis of the conclusions made by studies evaluating K17 expression at the protein vs. RNA level showed that the direction of association between K17 and clinical outcome appears consistent in breast, endometrial, esophageal, and renal cancer regardless of the assessment method used.